Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/16/2014US20140309202 High-strength testosterone undecanoate compositions
10/16/2014US20140309201 Compositions for Providing Vitamin D Year Round and Uses Thereof
10/16/2014US20140309199 9-aminomethyl substituted minocycline compounds
10/16/2014US20140309198 Method of treating acne
10/16/2014US20140309197 Stabilized pharmaceutical formulations comprising antineoplastic compounds
10/16/2014US20140309195 Small molecules that promote skin regeneration
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140309189 Highly active nucleoside derivative for the treatment of hcv
10/16/2014US20140309188 Use of pharmaceutical composition comprising deoxynucleoside and nucleoside for treatment of tumor
10/16/2014US20140309187 Solid forms of an antiviral compound
10/16/2014US20140309184 Methods and compositions for the treatment of ovarian cancer
10/16/2014US20140309183 Low-Dose Combination Chemotherapy
10/16/2014US20140309181 TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES
10/16/2014US20140309180 Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
10/16/2014US20140309179 Treatment of Glaucoma and Other Retinopathies with Gangliosides
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140309165 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
10/16/2014US20140309164 Deuterated nucleoside prodrugs useful for treating hcv
10/16/2014US20140308379 Use of flaxseed and flaxseed derivatives for treatment of neurological disorders and viral diseases
10/16/2014US20140308378 Bidens pilosa and polyacetylenic compounds for prevention and treatment of coccidiosis
10/16/2014US20140308376 Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin
10/16/2014US20140308369 Dietary product intended to reduce visceral fat during the pre-operative phase prior to bariatric surgery
10/16/2014US20140308368 Ophthalmological aqueous composition
10/16/2014US20140308363 Drug loaded polymeric nanoparticles and methods of making and using same
10/16/2014US20140308361 Composition for management of periodontal diseases
10/16/2014US20140308359 Easily dosable solid preparation
10/16/2014US20140308357 Melatonin-based solutions and powders for their preparation
10/16/2014US20140308356 Granular material for dosage forms
10/16/2014US20140308354 Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
10/16/2014US20140308353 Delivery of an active material
10/16/2014US20140308352 Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
10/16/2014US20140308351 Method of Forming Non-Immunogenic Hydrophobic Protein Nanoparticles, and Uses Therefor
10/16/2014US20140308350 Nsaid administration and related compositions, methods and systems
10/16/2014US20140308349 Pharmaceutical compositions
10/16/2014US20140308348 Flurbiprofen and muscle relaxant combinations
10/16/2014US20140308346 Combination therapy for effecting weight loss and treating obesity
10/16/2014US20140308345 Krill oil and reacted astaxanthin composition and associated method
10/16/2014US20140308344 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
10/16/2014US20140308342 Reprogramming urokinase into an antibody-recruiting anticancer agent
10/16/2014US20140308340 Method for selectively inhibiting acat1 in the treatment of neurodegenerative diseases
10/16/2014US20140308339 Lipophilic drug delivery vehicle and methods of use thereof
10/16/2014US20140308338 Dressings that contain active substance
10/16/2014US20140308336 Local drug delivery devices and methods for treating cancer
10/16/2014US20140308335 Transdermal preparation
10/16/2014US20140308326 Antimicrobial compositions of aminoglycosidic antibiotics and zinc ion chelators specifically formulated for enhanced inhibition of bacterial colonization and antibacterial efficacy
10/16/2014US20140308309 Composition comprising chlorella extract for preventing or treating liver disease
10/16/2014US20140308303 Method for selecting a candidate drug compound
10/16/2014US20140308300 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
10/16/2014US20140308296 PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
10/16/2014US20140308293 Reconstitution method for high concentration dry protein formulations
10/16/2014US20140308292 Family of pain producing substances and methods to produce novel analgesic drugs
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/16/2014US20140308284 Method of combination therapy using anti-c-met antibody and fgfr inhibitor
10/16/2014US20140308282 Pharmaceutical compounds
10/16/2014US20140308279 Anti-ErbB3 Antibodies and Uses Thereof
10/16/2014US20140308275 Methods for diagnosing and treating myhre syndrome
10/16/2014US20140308274 Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitors
10/16/2014US20140308260 Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
10/16/2014US20140308244 Combination Therapy for Treatment of Inflammatory Demyelinating Disease
10/16/2014US20140308243 Hepatitis c virus inhibitors
10/16/2014US20140308242 Biomarkers for hcv infected patients
10/16/2014US20140308234 Drug delivery polymer and uses thereof
10/16/2014US20140308223 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
10/16/2014US20140308216 Antimicrobial composition
10/16/2014US20140308214 Pharmaceutical Composition
10/16/2014US20140308212 Edible plant-derived microvesicle compositions for diagnosis and treatment of disease
10/16/2014US20140305835 Packaging and dispensing of rapid dissolve dosage form
10/14/2014USRE45198 Omeprazole solution and method for using same
10/14/2014US8862224 Method for treating neovascularization
10/14/2014US8859824 Dual cation dual anion coordination complexes
10/14/2014US8859802 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/14/2014US8859798 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
10/14/2014US8859783 Indirubin-3′-oxime derivatives as potent cyclin dependent kinase inhibitors
10/14/2014US8859780 Benzimidazole derivatives as selective blockers of persistent sodium current
10/14/2014US8859778 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
10/14/2014US8859777 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
10/14/2014US8859775 Pyrazolopyridinone derivatives as LPA receptor antagonists
10/14/2014US8859774 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
10/14/2014US8859773 N1/N2-lactam acetyl-CoA carboxylase inhibitors
10/14/2014US8859768 Heteroaryls and uses thereof
10/14/2014US8859761 Refining process of Cefamandole sodium
10/14/2014US8859760 Compositions for killing or preventing the growth of microbes
10/14/2014US8859759 Particulate-soluble glucan preparation
10/14/2014US8859752 SIRNA-based therapy of Fibrodyplasia Ossificans Progressiva (FOP)
10/14/2014US8859747 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859745 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859728 Peptides that target dorsal root ganglion neurons
10/14/2014US8859705 Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
10/14/2014US8859628 Method for preventing, treating and diagnosing disorders of protein aggregation
10/14/2014US8859627 Anti-microbial composition
10/14/2014US8859626 Anti-virulence compositions and methods
10/14/2014US8859625 Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses
10/14/2014US8859624 Stable rasagiline composition
10/14/2014US8859623 Methods and compositions of stable phenylephrine formulations
10/14/2014US8859622 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
10/14/2014US8859621 Pharmaceutical formulations of modafinil
10/14/2014US8859620 Phthalanilate compounds and methods of use
10/14/2014US8859619 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/14/2014US8859618 Silicone gel-based compositions for wound healing and scar reduction
10/14/2014US8859617 Use of furan alkyl for preparing an antidiabetic drug
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 7860